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Abstract
Selection of chemical markers is crucial for the quality control of herbal medicines, including
authentication of genuine species, harvesting the best quality raw materials, evaluation of post-
harvesting handling, assessment of intermediates and finished products, and detection of harmful
or toxic ingredients. Ideal chemical markers should be the therapeutic components of herbal
medicines. However, for most herbal medicines, the therapeutic components have not been fully
elucidated or easily monitored. Bioactive, characteristic, main, synergistic, correlative, toxic and
general components may be selected. This article reviews the effective use of chemical markers in
the quality control of herbal medicines including the selection criteria considering the roles and
physicochemical factors which may affect the effective use of chemical markers.
Background
Herbal medicines, also known as botanical medicines or
phytomedicines, refer to the medicinal products of plant
roots, leaves, barks, seeds, berries or flowers that can be
used to promote health and treat diseases. Medicinal use
of plants has a long history worldwide. According to the
World Health Organization (WHO), traditional herbal
preparations account for 30–50% of the total medicinal
consumption in China [1]. There have always been con-
cerns about the inconsistent composition of herbal medi-
cines and occasional cases of intoxication by adulterants
and/or toxic components. Quality control of herbal med-
icines aims to ensure their consistency, safety and efficacy.
Chemical fingerprinting has been demonstrated to be a
powerful technique for the quality control of herbal med-
icines. A chemical fingerprint is a unique pattern that indi-
cates the presence of multiple chemical markers within a
sample.
The European Medicines Agency (EMEA) defines chemi-
cal markers as chemically defined constituents or groups
of constituents of a herbal medicinal product which are of
interest for quality control purposes regardless whether
they possess any therapeutic activity [2]. Ideally, chemical
markers should be unique components that contribute to
the therapeutic effects of a herbal medicine. As only a
small number of chemical compounds were shown to
have clear pharmacological actions, other chemical com-
ponents are also used as markers. The quantity of a chem-
ical marker can be an indicator of the quality of a herbal
medicine.
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The overall quality of a herbal medicine may be affected
by many factors, including seasonal changes, harvesting
time, cultivation sites, post-harvesting processing, adulter-
ants or substitutes of raw materials, and procedures in
extraction and preparation. From harvesting to manufac-
turing, chemical markers play a crucial role in evaluating
the quality of herbal medicines. Moreover, the study of
chemical markers is applicable to many research areas,
including authentication of genuine species, search for
new resources or substitutes of raw materials, optimiza-
tion of extraction and purification methods, structure elu-
cidation and purity determination. Systematic
investigations using chemical markers may lead to discov-
eries and development of new drugs.
In this review, we summarise selection criteria for chemi-
cal markers and how chemical markers are used to evalu-
ate the quality of herbal medicines.
Selection of chemical markers
A total of 282 chemical markers are listed in the Chinese
Pharmacopoeia (2005 edition) for the quality control of
Chinese herbal medicines [3]. As discussed in the mono-
graphs of the American Herbal Pharmacopoeia (AHP),
the use of single or multiple chemical markers was impor-
tant to quality control [4]. Scientists and regulatory agen-
cies have paid attention to the selection of chemical
markers in quality control. The EMEA categorises chemi-
cal markers into analytical markers and active markers [2].
According to the definition by the EMEA, analytical mark-
ers are the constituents or groups of constituents that serve
solely for analytical purposes, whereas active markers are
the constituents or groups of constituents that contribute
to therapeutic activities. There are other classifications of
chemical markers. For example, Srinivasan proposed the
following four categories: active principles, active mark-
ers, analytical markers and negative markers [5]. Active
principles possess known clinical activities; active markers
contribute to clinical efficacy; analytical markers have no
clinical or pharmacological activities; negative markers
demonstrate allergenic or toxic properties. All markers
may contribute to the evaluation, standardisation and
safety assessment of herbal medicines. Lin et al. expanded
Srinivasan's classification into seven categories, namely
active principles, active markers, group markers, chemical
fingerprints, analytical markers, 'phantom' markers and
negative markers [6]. Group chemical markers have simi-
lar chemical structures and/or physical properties. The
pharmacological activities of individual components are
not necessarily known. Polysaccharides are classified
under this category. This type of markers is not necessarily
specific and can be easily masked by other components
especially in proprietary products. 'Phantom' markers are
constituents that have known pharmacological activities;
however, they can be undetectable in some herbal medi-
cines due to low quantities. Special care should be taken
when 'phantom' markers were selected as chemical mark-
ers for quality control [6]. While group chemical markers
have a lower resolving power in qualitative analysis,
chemical fingerprinting cannot provide adequate quanti-
tative information.
In this paper, we suggest a new classification of eight cat-
egories of chemical markers, namely (1) therapeutic com-
ponents, (2) bioactive components, (3) synergistic
components, (4) characteristic components, (5) main
components, (6) correlative components, (7) toxic com-
ponents, and (8) general components used with finger-
print spectrum. These eight categories are defined and
discussed in the subsequent sections.
Therapeutic components
Therapeutic components possess direct therapeutic effects
of a herbal medicine. They may be used as chemical mark-
ers for both qualitative and quantitative assessments.
Originated from the bulbs of Fritillaria species (family Lil-
iaceae), Bulbus Fritillariae (Beimu) is commonly prescribed
as an antitussive and expectorant in Chinese medicine
practice. Five different Bulbus Fritillariae derived from nine
Fritillaria species are documented in the Chinese Pharma-
copoeia [3]. Isosteroidal alkaloids of Bulbus Fritillariae,
including verticine, verticinone and imperialine, were
identified as the major therapeutic components that
account for the antitussive effect [7-9]. Therefore, isoster-
oidal alkaloids were selected as the chemical markers for
the quality assessment of Bulbus Fritillariae using a series
of chromatographic techniques such as pre-column deri-
vatizing gas chromatography – flame ionization detection
(GC-FID), direct GC-FID, gas chromatography – mass
spectrometry (GC-MS), pre-column derivatizing high-per-
formance liquid chromatography – ultraviolet detection
(HPLC-UV), high-performance liquid chromatography –
evaporative light scattering detection (HPLC-ELSD) and
high-performance liquid chromatography – mass spec-
trometry (HPLC-MS) methods [10].
Artemisinin from Herba Artemisiae Annuae (Qinghao) is
another example of therapeutic component. Herba Artem-
isiae Annuae is well known for its potent anti-malarial
activity [11]. Artemisinin inhibits Plasmodium falciparum
and Plasmodium vivax, two pathogens that cause malaria
[12,13]. Artemisinin is now used as a chemical marker in
HPLC-ELSD [14], GC-FID [15] and GC-MS [15,16] for
assessing the quality of the plant (parts and whole) at var-
ious stages [15], including the green and dead leaves of
the plant [16].Chinese Medicine 2008, 3:7 http://www.cmjournal.org/content/3/1/7
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Bioactive components
Bioactive components are structurally different chemicals
within a herbal medicine; while individual components
may not have direct therapeutic effects, the combination
of their bioactivities does contribute to the therapeutic
effects. Bioactive components may be used as chemical
markers for qualitative and quantitative assessment.
According to Chinese medicine theories, Radix Astragali
(Huangqi), derived from the roots of Astragalus mem-
branaceus (Fish.) Bge. or A. membranaceus var. mongholicus
(Bge.) Hsiao, is used to reinforce qi. Isoflavonoids, sapon-
ins and polysaccharides of Radix Astragali showed phar-
macological actions in immune and circulatory systems,
which were consistent with the Chinese medicine indica-
tions [17]. These bioactive components, including isofla-
vonoids and saponins, were used simultaneously in the
evaluation of the quality of Radix Astragali [18-20].
Synergistic components
Synergistic components do not contribute to the thera-
peutic effects or related bioactivities directly. However,
they act synergistically to reinforce the bioactivities of
other components, thereby modulating the therapeutic
effects of the herbal medicine. Synergistic components
may be used as chemical markers for qualitative and
quantitative assessment.
The products of St John's wort (Hypericum perforatum L.)
are popular for treating mild depression [21]. Butterweck
et al. reviewed the research progress on the phytochemis-
try and pharmacology of St John's wort [22,23]. Naph-
thodianthrone, hypericin, and hyperforin (a
phloroglucinol derivative) were identified as the major
components that contribute to the pharmacological activ-
ities of St John's wort. Rutin, a ubiquitous flavonoid of
natural products, demonstrated synergistic antidepressant
actions in St John's wort [24]. In a forced swimming test
on rats, extracts of St John's wort with various chemical
profiles were tested, among which the extract containing
about 3% of rutin showed positive effects, whereas the
extracts containing less than 3% of rutin were inactive.
The extracts became active when the level of rutin was
increased to about 3%. However, rutin alone did not
show any effects under the same conditions [24]. These
results suggest that chemicals in St John's wort work syn-
ergistically to achieve the antidepressant effects. There-
fore, naphthodianthrones, phloroglucinols and
flavonoids may be used as chemical markers for the qual-
ity control of St John's wort [25-29].
Characteristic components
While characteristic components may contribute to the
therapeutic effects, they must be specific and/or unique
ingredients of a herbal medicine.
Terpene lactones in the leaves of Ginkgo biloba L. (Yinxing)
exemplify characteristic components. EGb 761, a stand-
ardized leave extract of Ginkgo biloba is a well defined
product for the treatment of cardiovascular diseases,
memory loss and cognitive disorders associated with age-
related dementia [30]. Flavonoids and terpene lactones
are responsible for the medicinal effects of EGb 761 [31].
Flavonoids, terpene lactones including ginkgolides A, B
and C, and bilobalide are chemical markers for the quality
control of Ginkgo biloba leave extracts [31-34]. EGb 761
contains 6% of terpene lactones (2.8–3.4% of ginkgolides
A, B and C, and 2.6–3.2% of bilobalide) and 24% of fla-
vone glycosides. Aglycons are primarily quercetin, kaemp-
ferol and isorhamnetin.
Valerenic acids, the characteristic components of valerian
derived from the roots of Valeriana officinalis L., have sed-
ative effects and improve sleep quality [35,36]. Valerenic
acids are used as chemical markers to evaluate the quality
of valerian preparations although their sedative effects
have not been fully elucidated [37]. These chemical mark-
ers are also used for studying in vitro release of coated and
uncoated tablets [38] and stability test for valerian ground
materials and extracts [39].
Main components
Main components are the most abundant in a herbal
medicine (or significantly more abundant than other
components). They are not characteristic components and
their bioactivities may not be known. Main components
may be used for both qualitative and quantitative analysis
of herbal medicines especially for differentiation and sta-
bility evaluation.
Four well-known Chinese herbal medicines derived from
the genus Panax, namely (1) Radix et Rhizoma Ginseng
(Renshen), (2) Radix et Rhizoma Ginseng Rubra (Hongshen),
(3) Radix Panacis Quinquefolii (Xiyangshen) and (4) Radix
et Rhizoma Notoginseng (Sanqi) [39], contain triterpenoid
saponins including ginsenoside Rg1, Re, Rb1 and noto-
ginsenoside R1 as their main components [40-42].
Through qualitative and quantitative comparison of the
saponin profiles [43-45], these four herbs can be differen-
tiated from one another [42,46].
Herba Epimedii (Yinyanghuo), derived from the aerial parts
of Epimedium brevicornum Maxim., E. sagittatum (Sieb. et
Zucc.) Maxim., E. pubescens Maxim., E. wushanense T. S.
Ying or E. koreanum Nakai, has been traditionally used to
reinforce kidney-yang (shenyang), strengthen tendons and
bones, and relieve rheumatic conditions [47]. Flavonoids
including epimedin A, B, C and icariin are the main com-
ponents of Herba Epimedii [48]. A 24-month randomised,
double-blinded and placebo-controlled clinical study
showed that flavonoids from Herba Epimedii exerted ben-Chinese Medicine 2008, 3:7 http://www.cmjournal.org/content/3/1/7
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eficial effects on preventing osteopenia in late post-meno-
pausal women [49]. According to the Chinese
Pharmacopoeia (2005 edition), total flavonoids and icar-
iin are used as chemical markers for Herba Epimedii [47].
In a recent study, Chen et al. developed an HPLC method
to simultaneously quantify up to 15 flavonoids, of which
epimedin A, B, C and icariin were selected as chemical
markers for the quality assessment of the Epimedium spe-
cies documented in the Chinese Pharmacopoeia (2005
edition) [50].
Correlative components
Correlative components in herbal medicines have close
relationship with one another. For example, these compo-
nents may be the precursors, products or metabolites of a
chemical or enzymatic reaction. Correlative components
can be used as chemical markers to evaluate the quality of
herbal medicines originated from different geographical
regions and stored for different periods of time.
According to the Chinese Pharmacopoeia (2005 edition),
only psoralen and isopsoralen (Figure 1) are used as
chemical markers for assessing the quality of Fructus Psor-
aleae (Buguzhi) [51]. Recently, our group identified glyco-
sides, psoralenoside and isopsoralenoside (Figure 1)
found them useful as the chemical markers for Fructus Pso-
raleae  [52]. The levels of psoralen and isopsoralen are
inversely correlated to the level of glycosides psoraleno-
side and isopsoralenoside [53]. When extracted with 50%
methanol, samples had high levels of psoralen and isop-
soralen and a minute amount of psoralenoside and isop-
soralenoside. When moistened with 100% methanol,
dried and extracted with 50% methanol, samples con-
tained all four components. Psoralen and isopsoralen
may be the enzymatic reaction products of psoralenoside
and isopsoralenoside respectively. After incubation of a
psoralenoside and isopsoralenoside solution with β-glu-
cosidase at 36°C for 24 hours, the amount of psoralen
and isopsoralen became detected. Psoralenoside and
isopsoralenoside, therefore, may be used as chemical
markers for the quality control of Fructus Psoraleae [53].
Toxic components
Traditional Chinese medicine literature and modern toxi-
cological studies documented some toxic components of
medicinal herbs. For instance, aristolochic acids (AAs)
and pyrrolizidine alkaloids (PAs) may cause nephrotoxic-
ity and heptotoxicity respectively [54,55].
The use of three herbal medicines that contain AAs,
namely Radix Aristolochiae Fangchi (Guangfangji), Caulis
Aristolochiae Manshuriensis (Guanmutong) and Radix Aris-
tolochiae (Qingmuxiang), have been prohibited in China
since 2004 [56]. These three herbs were traditionally used
to relieve pain and treat arthritis. Radix et Rhizoma Asari
(Xixin) was traditionally sourced from the whole plants of
Asarum heterotropoides Fr. Schmidt var. mandshurcum
(maxim.) Kitag., A. sieboldii Miq. var. seoulense Nakai or A.
seiboldii Miq. Its medicinal use has now been officially
limited to the roots and rhizomes because the roots and
rhizomes contain a much lower level of AAs than the aer-
ial parts [57]. AAs are now used as markers to control
Psoralen, isopsoralen, psoralenoside, isopsoralenoside and their correlation in Psoralea corylifolia L Figure 1
Psoralen, isopsoralen, psoralenoside, isopsoralenoside and their correlation in Psoralea corylifolia L.Chinese Medicine 2008, 3:7 http://www.cmjournal.org/content/3/1/7
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nephrotoxic herbs and proprietary herbal products [58-
61].
There are over 6,000 plant species containing PAs which
can cause hepatic veno-occlusive disease [62]. There have
been various PA restriction guidelines issued by govern-
ment bodies and organisations. According to the WHO
guidelines issued in 1989, the lowest intake rate of toxic
PAs that may cause veno-occlusive disease in human is 15
μg/kg/day [63]. In 1993, the American Herbal Products
Association (AHPA) alerted its members to restrict the use
of comfrey, a herbal medicine that contains PAs for exter-
nal applications. In 2001, the Food and Drug Administra-
tion (FDA) of the United States recalled comfrey from all
dietary supplements [64]. In 2007, the Medicines and
Healthcare Products Regulatory Agency (MHRA) of the
United Kingdom advised all herbal interest groups to
withdraw all unlicensed proprietary products that may
contain hepatotoxic PAs from Senecio species [65]. PAs are
thus markers for detection of hepatotoxic components in
herbs [66-72].
General components coupled with 'fingerprints'
General components are common and specific compo-
nents present in a particular species, genus or family.
These components may be used with 'fingerprints' for
quality control purposes.
Lobetyolin, a polyacetylene compound, is used as a
marker for Radix Codonopsis (Dangshen) in thin-layer chro-
matography (TLC). Radix Codonopsis is derived from the
roots of three Codonopsis species, namely Codonopsis pilo-
sula  (Franch.) Nannf., C. pilosula Nannf. var. modesta
(Nannf.) L. T. Shen or C. tangshen Oliv. [73]. Our study
showed that other five Codonopsis species that are com-
mon substitutes of Radix Codonopsis also contain lobetyo-
lin. They are C.tubulosa Kom., C.subglobosa W. W. Smith, C.
clematidea  (Schynek) C. B. Cl., C.canescens  Nannf. and
C.lanceolata (Sieb. et Zucc.) Trautv. Moreover, the roots of
Campanumoea javanica Bl. and Platycodon grandiflorum
(Jacq.) A. DC. (familyCampanulaceae), which are easily
confused with Radix Codonopsis, also contained lobetyo-
lin. Therefore, lobetyolin may be used as a general chem-
ical marker coupled with HPLC-UV 'fingerprints' to
differentiate  Radix Codonopsis from its substitutes and
adulterants [74].
As a chemical component may have more than one
attribute, a component may belong to multiple categories.
For example, ginkgolides A, B and C, and bilobalide are
not only characteristic components, but also bioactive
components of Ginkgo biloba. Ginsenoside Rg1, Re and
Rb1 are both main and bioactive components of Panax
ginseng. Categories of chemical markers are summarised
in Table 1.
Applications of chemical markers
In this section, we describe cases to exemplify how chem-
ical markers are used to evaluate the quality of herbal
medicines in manufacturing, and as potential lead com-
pounds for new drug development.
Identification of adulterants
Derived from the resin of Garcinia hanburyi Hook f. (fam-
ily Guttiferae), gamboges (Tenghuang) has been used in
China to treat scabies, tinea and malignant boil [75], and
in Thailand to treat infected wounds, pain and oedema
[76]. Characteristic polyprenylated caged xanthones
including gambogic acid, gambogenic acid were isolated
as the main and bioactive components of gamboges [77].
In our previous study, an adulterant of gamboges was dif-
ferentiated from the authentic sample by an HPLC-UV
method using eight caged xanthones as chemical markers.
The chromatogram of gamboges had all eight com-
pounds, while the adulterant showed none of them (Fig-
ure 2).
Differentiation of herbal medicines with multiple sources
Radix Stemonae (Baibu) is a traditional antitussive and
insecticidal herbal medicine derived from the roots of
three Stemonae species, namely Stemona tuberosa Lour, S.
sessilifolia (Mig.) Mig. and S. japonica Mig. [78]. The Ste-
Table 1: Quality control interests and disadvantages of chemical markers
Category Quality control interests Disadvantages
Therapeutic components Indicating efficacy Not always obtained
Toxic components Safety assurance Need extensive toxicological studies
Bioactive components May indicate efficacy Not always indicate the overall quality
Main components Stability and consistency test Not always indicate the overall quality
Characteristic components Qualitative identification Not always obtained
Synergistic components Revealing synergistic actions of multi-components Need extensive pharmacological studies
Correlative components Prediction of storage period, extraction methods 
and sometimes collection site etc.
Need extensive phytochemical studies
General components used together with 
fingerprint spectrum
Indicating overall quality when used together with 
fingerprint spectrum
Mass data analysisChinese Medicine 2008, 3:7 http://www.cmjournal.org/content/3/1/7
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HPLC chromatograms of gamboges (A) and its adulterant (B) Figure 2
HPLC chromatograms of gamboges (A) and its adulterant (B). 1, Morellic acid; 2, R-30-hydroxygambogic acid; 3, S-
30-hydroxygambogic acid; 4, Gambogenic acid; 5, R-isogambogic acid; 6, S-isogambogic acid; 7, R-gambogic acid; 8, S-gambogic 
acid.
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mona  alkaloids were pharmacologically proven to be
responsible for the antitussive and insecticidal effects of
Radix Stemonae [79-83]. In our studies, we observed that
the chemical profiles of these three Stemona species varied
greatly. Croomine-typealkaloids such as croomine were
detected in all three species, while protostemonine-type
alkloids such as protostemonine and maistemonine were
detected in S. japonica and S. sessilifolia. Moreover, sti-
choneurine-type alkaloids such as stemoninine, neotu-
berostemonine and tuberostemonine were only found in
S. tuberosa. Stemona alkaloids may be used as markers to
discriminate the three Stemona species [84,85].
Determination of the best harvesting time
Rhizoma Chuanxiong (Chuanxiong) is one of the traditional
Chinese medicinal herbs frequently used to treat cerebro-
and cardio-vascular diseases. Various chemical com-
pounds have been isolated and identified from Rhizoma
Chuanxiong, including ferulic acid, senkyunolide I, senky-
unolide H, senkyunolide A, coniferyl ferulate, Z-ligusti-
lide, 3-butylidenephthalide, riligustilide and levistolide A
[86-92]. These chemicals have multiple biological activi-
ties which may contribute to the therapeutic effects of the
herb [93-99]. Thus, major bioactive components senkyu-
nolide A, coniferyl ferulate, Z-ligustilide, ferulic acid, 3-
butylidenephthalide, riligustilide and levistolide A may
be used as markers to select the best harvesting time. A
previous study using these markers suggested that the best
harvesting time for Rhizoma Chuanxiong is from mid April
to late May [100].
Confirmation of collection sites
In our studies on the chemistry and antitussive activities
of Radix Stemonae [101-103], four chemical profiles of S.
tuberosa of different geographic sources were characterised
using croomine, stemoninine, neotuberostemonine or
tuberostemonine as markers [102]. Moreover, the total
alkaloid of S. tuberosa exhibited various levels of antitus-
sive activities in a citric acid-induced guinea pig cough
model [82]. Croomine, stemoninine, neotuberostemo-
nine and tuberostemonine all possess significant antitus-
sive activities, however, croomine (croomine type) act on
the central nervous system pathway, whereas the other
three alkaloids (stichoneurine type) acted on the periph-
eral pathway of cough reflex [82]. In terms of safety, those
containing stichoneurine-type alkaloids are more suitable
Radix Stemonae sources than those containing croomine as
the major component. Croomine, stemoninine, neotu-
berostemonine, and tuberostemonine may be used as
markers to confirm the collection sites for S. tuberosa (e.g.
Shizhu and Erbian in Sichuan province, Masupo and
Baoshan in Yunnan province, Shanglin in Guangxi prov-
ince or Yudu in Jiangxi province, China) which contains
higher levels of stemoninine, neotuberostemonine or
tuberostemonine, and a low level of croomine [102].
Assessment of processing methods
In general practice, most herbs must be processed to
reduce toxicity. For example, Radix Aconiti (Chuanwu)
derived from the root of Aconitum carmichaeli Debx [104],
is a well known toxic and potent herbal medicine. Cases
of intoxication and even death were reported in China
and Japan [105-107]. The herb is processed by boiling in
water for 4–6 hours or steaming for 6–8 hours [108]. The
toxic components of this herb are diester-diterpene Aconi-
tum alkaloids, such as aconitine, mesaconitine and hypa-
conitine. When processed, these alkaloids hydrolyse into
their respective analogues collectively known as
monoester alkaloids [109]. Monoester alkaloids are much
less toxic than diester alkaloids [110]. These six Aconitum
alkaloids may be used to evaluate Radix Aconiti [111].
Quality evaluation of herbal parts
Traditionally,  Radix Astragali is graded according to its
diameter, length and physical appearance. Isoflavonoids
and saponins were recognised as the major bioactive com-
ponents attributed to the therapeutic effects of Radix Astra-
gali. These two types of components were used to evaluate
the quality of Radix Astragali in our study, in which 25
samples of Radix Astragali were collected from four culti-
vating regions in China [112]. The contents of 11 main
isoflavonoids and three major astragalosides were ana-
lysed. Contrary to the traditional notion, thin roots con-
tained more astragalosides than thick ones. Moreover, the
content of astragalosides in the bark were over 74-fold
higher than that in the xylem. There was no difference in
isoflavonoid content between the thin and thick roots, or
the bark and the xylem. These results suggest that the thin
root Radix Astragali is of better quality [112].
Identification and quantitative determination of proprietary products
Qingfu Guanjie Shu (QGS, also known as JCICM-6) cap-
sule is a proprietary product to treat rheumatoid arthritis.
QGS has significant suppressive effects on arthritic [113]
and acute inflammation in animal models [114]. The for-
mula of QGS is composed of five anti-inflammatory and
anti-arthritic herbs, namely Caulis Sinomenii, Radix Paeo-
niae Alba, Cortex Moutan, Rhizoma Curcumae Longae and
Radix Aconiti Lateralis Preparata. Sinomenine, paeoni-
florin, paeonol, cucurmin and hypaconitine are the major
constituents of the five herbs respectively, all of which
have significant in vivo and in vitro effects including anti-
inflammation, analgesia, anti-arthritis and immunosup-
pression [115-118]. Thus, HPLC methods were developed
with these five chemicals as markers in the manufacturing
process of QGS [111,119]. Immediately after production,
three batches of QGS products were examined and no
remarkable variations in terms of the five chemicals were
found [119].Chinese Medicine 2008, 3:7 http://www.cmjournal.org/content/3/1/7
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Stability test of proprietary products
Stability test is used to evaluate product quality over time
and determine recommended shelf life. The five markers
mentioned above were used as indicators to evaluate the
product stability of QGS. For example, the accelerated
conditional stability test was carried out with four time
points in a period of three months in chambers at 40 ±
2°C and 75 ± 5% of humidity. The five markers were quite
stable during the period; only paeonol showed a slight
decrease of 5% immediately after production [119].
Diagnosis of herbal intoxication
Toxic components may be used as chemical markers in
screening methods, e.g. rapid diagnosis of acute hidden
aconite poisoning in urine samples by HPLC-MS [107].
Five pairs of aconite alkaloids (i.e. aconitine and benzoy-
laconitine, yunaconitine and deacetyl-yunaconitine,
mesaconitine and benzoylmesaconitine, hypaconitine
and benzoylhypaconitine, and crasscauline A and
deacetyl-crasscauline A) were chosen as markers to
develop a LC-MS screening method. The screening
method was applied to a clinical investigation of 15 cases
of suspected herbal poisoning, of which 11 cases were
tested by LC-MS [107].
Lead compounds for new drug discovery
The components responsible for the therapeutic effects
may be investigated as lead compounds for new drug dis-
covery. Gambogic acid (Figure 2), one of the major caged
xanthones of gamboges, is used as a chemical marker for
quality control and safety evaluation of gamboges [120-
123]. As its cytotoxicity is attributed to cell apoptosis
induction [124-128], gambogic acid is a potential lead
compound for new anti-cancer drugs [124-126] and has
recently been approved by the State Food and Drug
Administration of China for clinical trials of cancer treat-
ment [129].
Problems
Chemical markers are indispensable to quality control of
herbal medicines; yet many problems remain to be
solved.
Shortage of chemical markers
At present, some herbs do not have markers for quality
control. According to the Chinese Pharmacopoeia (2005
edition), only 281 out of 551 herbs have one or two
chemical markers for quality control. A total of 282 chem-
ical markers have been listed [3] for qualitative or quanti-
tative analysis of herbs. Moreover, many herbal medicines
share the same chemical markers for quality control
(Table 2).
Unqualified purity
Inconsistency in quality is a common prolem among the
commercially available chemical markers. The overall
quality of chemical markers may be influenced by various
physical and chemical factors such as described and exem-
plified below.
Solvents
Gambogic acid is one of the major characteristic caged
xanthones in gamboges and is therefore an ideal chemical
marker for quality control. However, during the isolation
and purification processes, gambogic acid can be trans-
formed by the nucleophilic addition of methanol to the
olefinic bond at C-10 when stored in methanol solution
at room temperature (Figure 3) [130].
Temperature
Bioactive components of Radix Astragali, isoflavonoids
have been used as chemical markers in the quality control
of the herb [18-20]. The relative contents of flavonoids
Table 2: Chemical markers shared by various herbal medicines 
in the Chinese Pharmacopoeia (2005 English version)
Chemical marker Herb Page no
Paeoniflorin Radix Paeoniae Alba 222
Radix Paeoniae Rubra 223
Chlorogenic acid Flos Lonicerae 62
Folium Eucommiae 70
Flos Chrysanthemi 57
Folium Pyrrosiae 76
Flos Loniceae Japonicae 62
Herba Saussureae Involucratae 151
Hyperoside Folium Crataegi 69
Herba Hyperici Perforati 139
Rutin Folium Mori 74
Flos Sophorae 65
Herba Saussureae Involucratae 151
Naringin Exocarpium Citri Grandis 52
Fructus Aurantii 83
Rhizoma Drynariae 264
Berberine Rhizoma Coptidis 256
Cortex Phellodendron Amuren 47
Cortex Phellodendron Chinensis 48
Caulis Mahoniae 26
Quercetin Herba Euphobiae Humifusa 137
Folium Apocyni Veneti 67
Herba Lysimachiae 143
Ferulic acid Radix Angelicae Sinensis 191
Rhizoma et Radix Ligustici 266
Scutellarin Herba Scutellariae Barbatae 153
Herba Erigerontis 135
Osthole Fructus Cnidii 90
Radix Angenicae Pubescentis 190
Gentiopicrin Radix Gentianae Macrophyllae 216
Radix et Rhizoma Gentianae 204
Buddleoside Flos Buddlejae 54
Flos Chrysanthemi Indici 58Chinese Medicine 2008, 3:7 http://www.cmjournal.org/content/3/1/7
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varied significantly among samples obtained with differ-
ent extraction methods (Figure 4). The chemical profiles
of samples with microwave assisted extraction, reflux or
Soxhlet were compared. Isoflavonoid glycoside malonates
were converted into their respective glycosides or flavo-
noid glycons (Figure 5) during the prolonged conven-
tional extraction procedures with Soxhlet and reflux at
higher temperature [18].
Light
Cinnamaldehyde is the chemical marker for the quantita-
tive evaluation of Cortex Cinnamomi [131]. This com-
pound is light-sensitive. When exposed to light at room
temperature for six hours, 10% of the content of cin-
namaldehyde was lost; and 36 hours later, only 25% was
left (Figure 6). Later studies indicated that this compound
gradually transformed to crystallized cinnamic acid when
exposed to light (Figure 7).
Epimeric mixture
Stereoisomers of some phytochemicals often co-exist in
nature and are sometimes mistakenly isolated as 'pure'
compounds. Most stereoisomers possess very different
bioactivities from each other. Gambogic acid, a chemical
marker for the gamboges [120,121], has two epimers i.e.
2(R)-gambogic acid and 2(S)-gambogic acid in nature
[77,132]. The epimers have different inhibitory effects on
CYP2C9 which is an important enzyme in the liver. The
two epimers should be used as separate chemical markers
[77]. The two epimers were eluted as a fine peak on a C18
column; they can be separated on a C8 column under opti-
mized conditions [122,123].
Gambogic acid (1) and gambogoic acid (2) and the possible derivative schemes Figure 3
Gambogic acid (1) and gambogoic acid (2) and the possible derivative schemes.Chinese Medicine 2008, 3:7 http://www.cmjournal.org/content/3/1/7
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Conformations
Spectral complexity of a compound sometimes leads to
confusion on its purity. Biflavonoids, for instance, always
show substantial spectral complexity at the dimeric level
due to hindered rotation between the flavanone and the
flavanonol moieties around the C-3/C-8" axis. GB1
(3",4',4"',5,5",7',7"-heptahydroxy-3,8"-biflavanone) is a
major biflavanoids of Garcinia kola Heckel which is a
plant native to Nigeria and Ghana and is often chewed by
the locals for tooth cleaning. GB1 is an ideal marker for G.
kola. The NMR spectra of GB1 obtained at 21°C exhibited
two sets of signals, which appeared to be a mixture of two
characteristic conformations. When measured at 70°C
and 90°C, GB1 showed a single set of signals, the higher
the temperature, the faster the hindered rotation between
the flavanone and the flavanonol moieties around C-3/C-
8" axis. When the rotation was fast enough, the com-
pound existed at a relatively stable conformation, and the
spectral complexity at the dimeric level disappeared.
When measured at much lower temperatures such as -
30°C and -50°C, GB1 showed the same behaviour [133].
We finally confirmed that GB1 was a pure compound
[133].
Conclusion
Quality control of herbal medicines aims to ensure its
quality, safety and efficacy. Chemical markers are pivotal
in the current practice of quality control. Chemical mark-
ers should be used at various stages of the development
and manufacturing of a herbal medicine, such as authen-
tication and differentiation of species, collecting and har-
vesting, quality evaluation, stability assessment, diagnosis
of intoxication and discovery of lead compounds. Lack of
chemical markers remains a major problem for the quality
control of herbal medicines. In many cases, we do not
have sufficient chemical and pharmacological data of
chemical markers. Furthermore, there are many technical
challenges in the production of chemical markers. For
example, temperature, light and solvents often cause deg-
radation and/or transformation of purified components;
isomers and conformations may also cause confusions of
chemical markers.
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Determination of cinnamaldehyde samples exposed to light in different durations Figure 6
Determination of cinnamaldehyde samples exposed to light in different durations.
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